Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.
Patel M, Gangemi A, Marron R, Chowdhury J, Yousef I, Zheng M, Mills N, Tragesser L, Giurintano J, Gupta R, Gordon M, Rali P, D'Alonso G, Fleece D, Zhao H, Patlakh N, Criner G.
Patel M, et al. Among authors: fleece d.
BMJ Open Respir Res. 2020 Aug;7(1):e000650. doi: 10.1136/bmjresp-2020-000650.
BMJ Open Respir Res. 2020.
PMID: 32847947
Free PMC article.